MARKET

IBB

IBB

iShares Nasdaq Biotechnology ETF
NASDAQ

Real-time Quotes | Provided by Morningstar

151.58
-1.68
-1.10%
After Hours: 151.27 -0.32 -0.21% 17:30 04/19 EDT
OPEN
152.52
PREV CLOSE
153.26
HIGH
153.67
LOW
150.68
VOLUME
2.03M
TURNOVER
--
52 WEEK HIGH
174.04
52 WEEK LOW
119.65
TOTAL ASSET
9.98B
YTD YIELD
8.08%
1D
5D
1M
3M
1Y
5Y
Sector Update: Health Care Stocks Trade Lower Premarket Monday
MT Newswires · 21h ago
The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs
Biotech stocks reversed course in the week ended April 16, with the sector rebounding along with the broader market. The week's news flow was fairly light. The American Association of Cancer Research's annual meeting provided a platform for oncology-focuse...
Benzinga · 2d ago
The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15)
Benzinga · 3d ago
Sector Update: Health Care Stocks Trade Higher Premarket Friday
MT Newswires · 3d ago
The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14)
Benzinga · 4d ago
Sector Update: Health Care Stocks Gain Premarket Thursday
MT Newswires · 4d ago
The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 13)
Benzinga · 5d ago
The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 12)
Benzinga · 6d ago
More
No Data
Learn about the latest financial forecast of IBB. Analyze the recent business situations of iShares Nasdaq Biotechnology ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
08/31/2020
10 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-3.6936%
--
1-Week
-1.9739%
--
1-Month
-6.1662%
--
3-Month
-1.8936%
--
6-Month
11.9477%
--
YTD
8.0849%
--
1-Year
29.1046%
--
3-Year
5.3735%
--
5-Year
3.1086%
--
10-Year
17.0547%
--
Since Inception
7.3696%
--
No Data
No Data
  • All
No Data
Profile
Fund Name
iShares Nasdaq Biotechnology ETF
Risk
Low risk
Inception Date
2001-02-05
Benchmark
Dow Jones US Healthcare TR
Advisor Company
iShares
Custodian
State Street Bank & Trust Co
Manager
Team Managed